FGF23 has been identified as an early biomarker of impaired kidney function, as FGF23 levels rise prior to the development of hyperphosphatemia, 1,25-(OH)2D3 deficiency, hypocalcemia, or secondary hyperparathyroidism1,2. The gene discussed is FGF23; the disease is Hypocalcemia.